In addition to CSF1 and IL-4-mediated TAM reprogramming, the chemokine CXCL16 released from tumor cells has also been shown to bind to CXCR6 on microglia cells and drive them toward a pro-tumor phenotype [32]. Here, CXCR6 is linked to neoplasm.